Leitlinie empfiehlt orale Immuntherapie bei Erdnussallergie
Crossref DOI link: https://doi.org/10.1007/s15007-021-4925-3
Published Online: 2021-11-08
Published Print: 2021-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Facharztmagazine, Redaktion
Text and Data Mining valid from 2021-11-01
Version of Record valid from 2021-11-01
Article History
First Online: 8 November 2021
Free to read: This content has been made available to all.